Palvella Therapeutics (PVLA) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2023)
Palvella Therapeutics (PVLA) Property, Plant & Equipment (Net) Growth (1y) (2014 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Palvella Therapeutics |
1.42 Bn |
1.16 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
-7.27% |
| Mar 31, 2023 |
-11.37% |
| Dec 31, 2022 |
-11.14% |
| Sep 30, 2022 |
-18.95% |
| Jun 30, 2022 |
-14.45% |
| Mar 31, 2022 |
-8.11% |
| Dec 31, 2021 |
-13.26% |
| Sep 30, 2021 |
-8.33% |
| Jun 30, 2021 |
-0.65% |
| Mar 31, 2021 |
0.83% |
| Dec 31, 2020 |
13.04% |
| Sep 30, 2020 |
94.36% |
| Jun 30, 2020 |
159.96% |
| Mar 31, 2020 |
315.78% |
| Dec 31, 2019 |
286.25% |
| Sep 30, 2019 |
134.86% |
| Jun 30, 2019 |
71.59% |
| Mar 31, 2019 |
10.08% |
| Dec 31, 2018 |
25.16% |
| Sep 30, 2018 |
35.64% |
